OVER 2 YEARS OF
2600+ individuals with SMA have been treated with SPINRAZA in the US.* They range in age from 3 days† to 79 years:‡
of individuals are adults
of individuals treated with SPINRAZA are in the maintenance dosing phase
of individuals who started on SPINRAZA remain on treatment
*Based on commercial patients in the US (including Puerto Rico) as of December 2018.
†Includes clinical trial patients.
‡Clinical studies of SPINRAZA did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger patients.
Sign up with us to receive the latest news, support information, and upcoming events.
SPINRAZA was evaluated in a broad range of SMA types and levels of function
Individual results may vary based on several factors, including severity of disease, initiation of treatment, and duration of therapy.
Watch stories of the unlocked potential in individuals treated with SPINRAZA
Your circle of support
Find out how SMA360° can help with insurance and treatment logistics.*
*SMA360° services from Biogen are available only to those who have been prescribed SPINRAZA.
SMA360° is intended for US residents only.